ABBV: This Top Biotech Just Went On A Buying Spree By: TalkMarkets January 25, 2024 at 07:00 AM EST AbbVie stock is a buy following its recent merger & acquisition activity (Immunogen and Cerevel). Read More >> Related Stocks: AbbVie Amgen Cerevel Therapeutics Hldg Inc Immunogen Inc Karuna Therapeutics Inc
